Rising Insurance Costs Linked to Climate Crisis Hit US Homeowners Hard

US
Published:

Homeowners across the United States are facing steep increases in insurance premiums, primarily due to the escalating climate crisis, according to a report released by the US Treasury Department. The analysis reveals that individuals living in high-risk areas for climate-related disasters, such as wildfires and hurricanes, are enduring the most significant hikes, with premiums rising an average of 82% compared to those in safer regions over a four-year period leading up to 2022.

As insurance companies struggle to operate amid increasing climate risks, many have paused or withdrawn their policies, particularly in states like Florida and California, which are currently dealing with severe wildfire incidents. The report highlights that more homeowners are unable to pay these soaring premiums, raising the risk of policy cancellations. Notably, insurers canceled at least 10% of policies in over 150 high-risk zip codes in 2022.

David Jones, a former insurance commissioner in California, warned that "the climate crisis is driving an insurance crisis" and emphasized that the report illustrates the tangible costs associated with climate change. Janet Yellen, the Treasury Secretary, called attention to the dangerous trends of rising insurance costs and availability issues that threaten the long-term financial stability of American families.

In response to the insurance crisis, some states are setting up backup insurance options as companies halt writing new policies. The recent fires in Los Angeles, which could be among the most costly in California history, may further exacerbate these trends.

As the climate crisis continues to impact the housing and insurance markets, experts warn that obtaining mortgages might become increasingly difficult for many Americans, particularly as insurance is a requisite for home financing.

Weekly Newsletter

News summary by melangenews

Loading...

More from United States

Tragic Collision of Passenger Plane and Military Helicopter in Washington Claims 67 Lives

A catastrophic midair collision between a passenger plane and a military helicopter in Washington D.C. on Wednesday resulted in the deaths of all 67 individuals on board. The incident involved American Airlines flight 5342, which was a Bombardier CRJ-700 carrying 60 passengers and four crew members, and a military Sikorsky H-60 Black Hawk helicopter occupied by three service members. The collision occurred over the Potomac River at approximately 8:48 PM local time while the plane was making its final approach to Ronald Reagan Airport. Eyewitness reports indicated that the helicopter veered dangerously close to the aircraft before the impact, causing both to explode in midair. Emergency teams recovered 28 bodies from the plane and one from the helicopter, confirming that no survivors emerged from the wreckage. American Airlines expressed its condolences and stated that it is cooperating with investigation efforts, while President Donald Trump commented on the tragedy, stating it "seemed avoidable" given the clear weather conditions and routine approach procedure. A joint investigation by civil and military authorities is underway to determine the accident's cause.
US

FDA Approves Revolutionary Bioengineered Blood Vessel for Trauma Treatments

The U.S. Food and Drug Administration (FDA) has approved a groundbreaking bioengineered blood vessel aimed at addressing the needs of trauma patients. Developed by North Carolina-based Humacyte, this vessel is designed to integrate with a patient’s body over time, providing a solution for individuals who have suffered severe injuries that impede blood circulation, particularly in cases of amputation. According to founder and CEO Laura Niklason, traditional treatments using veins are often inadequate, especially when patients cannot provide usable options from their own bodies. The FDA approval follows extensive testing involving 51 civilian and 16 military patients, revealing that nearly 92% of the engineered vessels remained functional after 30 days, compared to 79% for synthetic alternatives. Additionally, the infection rate for the bioengineered vessels was under 1%, significantly lower than the over 8% rate associated with synthetic grafts, as published in the journal JAMA Surgery. While the approved application is limited to trauma cases, Humacyte is exploring additional uses for its technology, including potential applications in kidney dialysis and peripheral artery disease.
US

Trump Plans to Detain 30,000 Migrants at Guantanamo Bay

Former President Donald Trump has outlined a controversial plan to detain up to 30,000 migrants at the Guantanamo Bay detention facility if he is re-elected in 2024. According to a statement released by Trump's campaign, this measure aims to address illegal immigration and bolster national security. This proposal comes amidst intensifying discussions on immigration policies in the United States, reflecting Trump's previously embraced hardline stance during his presidency. Trump's administration was marked by strict immigration measures, including family separations and the construction of barriers along the U.S.-Mexico border. Critics of the plan have raised concerns about humanitarian implications and the legality of detaining a large number of migrants indefinitely. Legal experts argue that such actions could face significant pushback in courts. The proposal reflects a broader trend among certain political leaders advocating for stringent immigration control as a response to increasing cross-border migration. As the 2024 presidential election approaches, Trump's immigration policy is expected to be a focal point of debate among candidates.
US